Cidara Therapeutics, Inc. (CDTX) Covered Calls
There are no covered calls available for Cidara Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-infectives for the treatment of diseases. Its lead product candidate is rezafungin acetate, a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, fungal infections associated with high mortality rates. It is also developing antibody-drug conjugates for multidrug-resistant bacterial infections that directly kill pathogens and also direct a patient's immune system to attack and eliminate bacterial, fungal, or viral pathogens. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in June 2014. Cidara Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
| Top 10 Open Interest For Jan 16 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SLV covered calls | 1. | CRVS covered calls | |
| 2. | IBIT covered calls | 7. | SPY covered calls | 2. | WYFI covered calls | |
| 3. | TLT covered calls | 8. | NFLX covered calls | 3. | OCUL covered calls | |
| 4. | INTC covered calls | 9. | QQQ covered calls | 4. | TLRY covered calls | |
| 5. | AAPL covered calls | 10. | GLD covered calls | 5. | METC covered calls | |
Want more examples? CDNS Covered Calls | CDW Covered Calls
